In patients with acute ischemic stroke (AIS), the assessment of left ventricular thrombus (LVT) is essential. In this study, we showed the utility of the early phase of gadolinium enhancement for detecting LVT in AIS patients, which conventional TTE hardly identified. CE-CMR, when using the early phase of gadolinium enhancement, should be performed on acute ischemic stroke patients, especially those with prior myocardial infarction or LV dysfunction and without definitive stroke etiologies.
This abstract and the presentation materials are available to members only; a login is required.